AAAAAA

   
Results: 1-7 |
Results: 7
Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha(1a)-adrenergic receptor antagonists
Authors: Lagu, B Tian, D Chiu, G Nagarathnam, D Fang, J Shen, QR Forray, C Ransom, RW Chang, RSL Vyas, KP Zhang, KY Gluchowski, C
Citation: B. Lagu et al., Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha(1a)-adrenergic receptor antagonists, BIOORG MED, 10(2), 2000, pp. 175-178
Pressure ionization in dense plasmas
Authors: Chiu, G Ng, A
Citation: G. Chiu et A. Ng, Pressure ionization in dense plasmas, PHYS REV E, 59(1), 1999, pp. 1024-1032
Design and synthesis of novel dihydropyridine alpha-1A antagonists
Authors: Marzabadi, MR Hong, XF Nagarathnam, D Miao, SW Chiu, G Wong, WC Wetzel, JM Fang, J Forray, C Chen, TB O'Malley, SS Chang, RSL Gluchowski, C
Citation: Mr. Marzabadi et al., Design and synthesis of novel dihydropyridine alpha-1A antagonists, BIOORG MED, 9(19), 1999, pp. 2843-2848
Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones
Authors: Nagarathnam, D Miao, SW Lagu, B Chiu, G Fang, J Dhar, TGM Zhang, J Tyagarajan, S Marzabadi, MR Zhang, FQ Wong, WC Sun, WY Tian, D Wetzel, JM Forray, C Chang, RSL Broten, TP Ransom, RW Schorn, TW Chen, TB O'Malley, S Kling, P Schneck, K Bendesky, R Harrell, CM Vyas, KP Gluchowski, C
Citation: D. Nagarathnam et al., Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones, J MED CHEM, 42(23), 1999, pp. 4764-4777
Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification oflinker and 4-methoxycarbonyl-4-phenylpiperidine moiety
Authors: Dhar, TGM Nagarathnam, D Marzabadi, MR Lagu, B Wong, WC Chiu, G Tyagarajan, S Miao, SW Zhang, FQ Sun, WY Tian, D Shen, QR Zhang, J Wetzel, JM Forray, C Chang, RSL Broten, TP Schorn, TW Chen, TB O'Malley, S Ransom, R Schneck, K Bendesky, R Harrell, CM Vyas, KP Zhang, KY Gilbert, J Pettibone, DJ Patane, MA Bock, MG Freidinger, RM Gluchowski, C
Citation: Tgm. Dhar et al., Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification oflinker and 4-methoxycarbonyl-4-phenylpiperidine moiety, J MED CHEM, 42(23), 1999, pp. 4778-4793
Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains
Authors: Lagu, B Tian, D Nagarathnam, D Marzabadi, MR Wong, WC Miao, SW Zhang, FQ Sun, WY Chiu, G Fang, J Forray, C Chang, RSL Ransom, RW Chen, TB O'Malley, S Zhang, KY Vyas, KP Gluchowski, C
Citation: B. Lagu et al., Design and synthesis of novel alpha(1a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains, J MED CHEM, 42(23), 1999, pp. 4794-4803
Design and synthesis of novel alpha(1a) adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia
Authors: Nagarathnam, D Wetzel, JM Miao, SW Marzabadi, MR Chiu, G Wong, WC Hong, XF Fang, J Forray, C Branchek, TA Heydorn, WE Chang, RSL Broten, T Schorn, TW Gluchowski, C
Citation: D. Nagarathnam et al., Design and synthesis of novel alpha(1a) adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia, J MED CHEM, 41(26), 1998, pp. 5320-5333
Risultati: 1-7 |